Top of this page
Skip navigation, go straight to the content
Categories
-
UCB and patients: partners in innovation
Posted by Xavier Hormaechea, Public Affairs 11-May-2012
UCB is working with patients on a new project designed to improve awareness of how new medicines are developed.
-
Researchers explore ‘personalised’ treatments
Posted by Ingrid Pansar, Medical Immunology Northern Europe 11-May-2012
-
It’s World Lupus Day
Posted by Kristel Santens, New Product Planning & Portfolio Management 10-May-2012
-
Laying the foundations of the biotech future
Posted by France Nivelle, Global Communications & Change Support 08-May-2012
-
More than motion: a new online community for Parkinson’s disease
Posted by Andrea Levin, Public Relations & Communications, UCB, Inc. 07-May-2012
-
2012 gets off on the right foot
Posted by Antje Witte, Investor Relations 26-Apr-2012
Net sales of UCB’s three core medicines were up 50% in the first three months of 2012 compared with the same period last year. That’s one of take-home messages for the year so far. The other one is a significant pipeline performance.
-
Journalists recognised for epilepsy reporting
Posted by Eimear O'Brien, Brand Communications 18-Apr-2012
-
Supporting communication on World Parkinson’s Disease Day
Posted by Eimear O'Brien, Brand Communications 11-Apr-2012
-
Good news ahead of Easter
Posted by Antje Witte, Investor Relations 06-Apr-2012
-
UCB supports patient organisations in Europe
Posted by Marie Vandepaer, Compliance Awareness and Prevention Corporate Compliance 02-Apr-2012
At UCB we are proud to support the work of a variety of patient organisations and are happy to share this information with the public.
